Skip to main content

Table 1 Background characteristics of the patients with and without prior myocardial infarction (PMI)

From: The ratio of serum n-3 to n-6 polyunsaturated fatty acids is associated with diabetes mellitus in patients with prior myocardial infarction: a multicenter cross-sectional study

Variable

PMI patients

P value

+

-

N

303

1430

 

Age, y.o

64.5 ± 10.6

64.5 ± 11.5

0.53

Male, n

272 (89.8%)

1076 (79.82%)

<0.001

BMI, kg/m2

24.4 ± 3.4

24.35 ± 3.5

0.81

HTN, n

225 (74.3%)

1042 (72.9%)

0.62

DM, n

144 (47.5%)

536 (37.5%)

<0.01

DL, n

245 (80.9%)

975 (68.2%)

<0.001

Smoking, n

155 (51.2%)

626 (43.8%)

0.02

FH, n

70 (23.1%)

251 (17.6%)

0.02

eGFRa, ml/min/1.73 m2

67.1 ± 19.2

69.01 ± 17.3

0.95

LDL, mg/dL

104.1 ± 29.5

112.4 ± 30.5

<0.001

TGL, mg/dL

147.3 ± 87.8

146.7 ± 97.2

0.53

HbA1cb, %

6.0 ± 1.2

5.8 ± 1.1

0.06

UAc, mg/dL

6.1 ± 1.4

5.8 ± 1.4

0.97

BNPd, pg/mL

85.1 ± 156.3

49.1 ± 73.3

<0.001

hs-CRP, mg/dL

0.23 ± 0.6

0.26 ± 0.8

0.63

Statin, n

216 (71.3%)

704 (49.2%)

<0.001

BB, n

141 (46.5%)

528 (36.9%)

<0.01

ARB or ACEi, n

185 (61.1%)

694 (48.5%)

<0.001

EPA, μg/mL

68.6 ± 36.4

74.96 ± 45.41

0.02

DHA, μg/mL

135.6 ± 49.1

145.1 ± 53.4

<0.01

AA, μg/mL

154.4 ± 38.4

158.1 ± 51.6

0.25

DHLA, μg/mL

32.8 ± 11.8

33.3 ± 12.4

0.49

EPA/AA

0.47 ± 0.3

0.50 ± 0.3

0.08

DHA/AA

0.91 ± 0.3

0.96 ± 0.4

0.03

EPA + DHA/AA + DHLA

1.14 ± 0.5

1.19 ± 0.5

0.07

  1. Continuous variables are presented as means ± standard deviations. Categorical variables are presented as percentages
  2. BMI body mass index, HTN hypertension, DM diabetes mellitus, DL dyslipidemia, FH family history of coronary artery disease, eGFR estimated glomerular filtration rate, LDL-C low-density lipoprotein cholesterol, TGL triglycerides, HbA1c hemoglobin A1c, UA uremic acid, BNP brain natriuretic peptide, hs-CRP high-sensitivity C-reactive protein, BB beta blockers, ACE-I angiotensin converting enzyme inhibitors, ARB angiotensin receptor blockers, EPA eicosapentaenoic acid, DHA docosahexaenoic acid, AA arachidonic acid, DHLA dihomo-γ-linolenic acid, EPA/AA ratio of EPA to AA levels, DHA/AA ratio of DHA to AA levels, PUFA polyunsaturated fatty acid
  3. anumbers of patients were 247 vs. 1123 (with PMI vs. without PMI, respectively), bnumbers of patients were 245 vs. 1103 (same as above), cnumbers of patients were 110 vs. 616 (same as above), dnumbers of patients were 106 vs. 567 (same as above)
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us